awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47138585-633AC476-0F38-41F2-AFAC-3D6C7E19978D
Q47138585-633AC476-0F38-41F2-AFAC-3D6C7E19978D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47138585-633AC476-0F38-41F2-AFAC-3D6C7E19978D
Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation.
P2860
Q47138585-633AC476-0F38-41F2-AFAC-3D6C7E19978D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47138585-633AC476-0F38-41F2-AFAC-3D6C7E19978D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d29ec27e098e77f466a974b14d5a0bbde26fc6c5
P2860
Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.